LEUNASE FOR INJECTION 10,000 iu/vial

[INDICATIONS]

Acute leukemia (including blastic crisis in chronic leukemia), malignant lymphoma.

CONTRAINDICATIONS

(LEUNASE Inj. is contraindicated in the following patients.)

Patients with a history of serious hypersensitivity to any of the components of the product.

[DOSAGE AND ADMINISTRATION]

The usual dose is 50 to 200 KU/kg to be administered by intravenous drip infusion every day or every other day. The dosage may be adjusted depending on the age and condition of the patient.

(Preparation)

See 7. Precautions Concerning Use – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information.